EUVIMEDObjevte EUVIMED
Vergleichsstudie

Integrative Multi‐Omics and Molecular Simulations Identify PRKCD as a Biological Modulator in Colon Adenocarcinoma: Validation With Phoenix dactylifera Phytochemicals and Comparison With Rottlerin

Mohd Adnan iD, Arif Jamal Siddiqui iD, Mousa Alreshidi, Malvi Surti iD, Mitesh Patel iD

Chemical Biology & Drug Design · 2026-05 · 107 (5)

DOI: 10.1111/cbdd.70302 ↗

At a glance

Vergleichsstudie in Chemical Biology & Drug Design, published online on 2026-04-29. Written by Mohd Adnan and 4 co-authors. Institution: Department of Biology, College of Science, University of Ha'il, Ha'il, Saudi Arabia. Major MEDLINE topics: Protein Kinase C-delta, Adenocarcinoma, Phytochemicals, Stilbenes. 30 references. Funded by: University of Hail.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Colorectal cancer (CRC) is the leading cause of cancer‐related deaths worldwide. Colon adenocarcinoma (COAD), the most common histological subtype, is characterized by a poor prognosis in advanced stages due to significant molecular heterogeneity. Protein kinase C delta (PKCδ), encoded by PRKCD, is a context‐dependent regulatory kinase in tumor biology. Its expression, genomic alterations, and binding interactions with phytochemicals from Phoenix dactylifera were studied using a comprehensive in silico approach. PRKCD was found to be downregulated in all TCGA‐COAD tumor subgroups when compared to normal tissue. The survival analysis failed to show a statistically significant association between PRKCD expression and overall or disease‐free survival; thus, the protein is more likely to be a biological modulator than a prognostic marker. Mutational profiling revealed missense substitutions and copy number variations in COAD. The drug‐like properties of 46 phytochemicals from P. dactylifera were evaluated, and only five compounds passed all the filters. Docking against the C2 regulatory domain of PKCδ (PDB ID: 1YRK) revealed (Z)‐4‐Methoxy‐3,3′,5,5′‐tetrahydroxystilbene (PubChem CID: 13499471) as the highest‐scoring ligand at −7.0 kcal/mol. Rottlerin, the validated PKCδ inhibitor, was used as a positive control and had a score of −7.3 kcal/mol at the same binding site. Both complexes were subjected to 100 ns molecular dynamics (MD) simulations under equated conditions. Several parameters, including backbone RMSD, RMSF, radius of gyration (Rg), solvent‐accessible surface area (SASA), hydrogen‐bond counts, principal component analysis (PCA), and free‐energy landscape (FEL) profiling, all indicated stable conformations for the two complexes. The lead phytocompound showed very similar behaviour to the positive control, thereby reinforcing its potential as a PRKCD modulator. The results indicate that further experimental studies on P. dactylifera ‐derived stilbenoids in COAD are warranted.

Subjects

MeSH terms (MEDLINE)

Protein Kinase C-deltaAdenocarcinomaPhytochemicalsStilbenesColonic NeoplasmsAcetophenonesPhoeniceaeBenzopyransMolecular Docking SimulationHumansMolecular Dynamics SimulationBinding Sites

Author keywords

PRKCDcolorectal cancercomparative molecular dynamicsgene expressionin silico analysismolecular dockingphytochemicalspositive control

Substances

Protein Kinase C-deltarottlerinPhytochemicalsStilbenesAcetophenonesBenzopyrans

Authors and institutions

  • Department of Biology, College of Science, University of Ha'il, Ha'il, Saudi Arabia.
  • Medical and Diagnostic Research Centre, University of Ha'il, Ha'il, Saudi Arabia.
  • Research and Development Cell (RDC), Parul Institute of Applied Sciences, Parul University, Vadodara, Gujarat, India.
  • Department of Biotechnology, Parul Institute of Applied Sciences, Parul University, Vadodara, Gujarat, India.
  • Department of Bioinformatics, Faculty of Engineering and Technology, Marwadi University, Rajkot, Gujarat, India.

ORCID profiles: Mohd Adnan, Arif Jamal Siddiqui, Malvi Surti, Mitesh Patel

Funding

  • University of Hail

Cite

APA

Adnan, M., Siddiqui, A. J., Alreshidi, M., Surti, M., & Patel, M. (2026). Integrative Multi‐Omics and Molecular Simulations Identify PRKCD as a Biological Modulator in Colon Adenocarcinoma: Validation With Phoenix dactylifera Phytochemicals and Comparison With Rottlerin. Chemical Biology & Drug Design, 107(5). https://doi.org/10.1111/cbdd.70302

Vancouver

Adnan M, Siddiqui AJ, Alreshidi M, Surti M, Patel M. Integrative Multi‐Omics and Molecular Simulations Identify PRKCD as a Biological Modulator in Colon Adenocarcinoma: Validation With Phoenix dactylifera Phytochemicals and Comparison With Rottlerin. Chemical Biology & Drug Design. 2026;107(5). doi:10.1111/cbdd.70302

BibTeX
@article{Adnan2026,
  author = {Adnan, Mohd and Siddiqui, Arif Jamal and Alreshidi, Mousa and Surti, Malvi and Patel, Mitesh},
  title = {Integrative Multi‐Omics and Molecular Simulations Identify PRKCD as a Biological Modulator in Colon Adenocarcinoma: Validation With Phoenix dactylifera Phytochemicals and Comparison With Rottlerin},
  journal = {Chemical Biology & Drug Design},
  year = {2026},
  volume = {107},
  number = {5},
  doi = {10.1111/cbdd.70302}
}
Start for free →